Friday, March 13, 2026

​

​​

​​

​​​

​​

Industry-Sponsored Satellite Symposium

12.30 - 13.00 hrs​

​

Evolving Therapy: BCMA-Directed Treatments for First Relapse in Multiple Myeloma

​

12.30 - 12.42 hrs

BCMA‑Directed Therapies at First Relapse — How do I decide Correctly?

Marcus Hentrich (Rotkreuzklinikum München)

​

12.42 - 12.54 hrs

BCMA-Directed Therapies - Opportunities for Office-based Hematologists in Multiple Myeloma

Michael Fiegl (Hämatologie Onkologie Germering)

​

12.54 - 13.00 hrs

Discussion